tiprankstipranks
Lee & Man Chemical Co. Ltd. (HK:0746)
:0746
Hong Kong Market

Lee & Man Chemical Co. Ltd. (0746) AI Stock Analysis

0 Followers

Top Page

HK:0746

Lee & Man Chemical Co. Ltd.

(0746)

Select Model
Select Model
Select Model
Neutral 69 (OpenAI - 5.2)
Rating:69Neutral
Price Target:
HK$5.50
▲(5.16% Upside)
Action:DowngradedDate:03/30/26
The score is driven primarily by solid financial resilience (low leverage and positive free cash flow) and attractive valuation (low P/E and high dividend yield). These positives are partially offset by weak technicals, with the stock trading below key moving averages and negative MACD despite oversold momentum readings.
Positive Factors
Conservative balance sheet
Lee & Man's low debt-to-equity (≈0.11–0.19) and growing equity provide structural financial resilience through cycles. This conservative financing lowers default risk, preserves borrowing capacity for capex or working-capital needs, and supports steady dividend and investment decisions over the medium term.
Negative Factors
Cyclicality of results
The company operates in a cyclical segment: sharp declines in 2023–2024 followed by a 2025 rebound show earnings volatility. This structural cyclicality creates uncertain cash flows and planning risk, making multi-quarter forecasting and capital allocation decisions more challenging for investors and management.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Lee & Man's low debt-to-equity (≈0.11–0.19) and growing equity provide structural financial resilience through cycles. This conservative financing lowers default risk, preserves borrowing capacity for capex or working-capital needs, and supports steady dividend and investment decisions over the medium term.
Read all positive factors

Lee & Man Chemical Co. Ltd. (0746) vs. iShares MSCI Hong Kong ETF (EWH)

Lee & Man Chemical Co. Ltd. Business Overview & Revenue Model

Company Description
Lee & Man Chemical Company Limited, an investment holding company, manufactures and sells chemical products in the People's Republic of China. It operates through two segments, Chemical and Property. The company offers caustic soda, chloromethane ...
How the Company Makes Money
null...

Lee & Man Chemical Co. Ltd. Financial Statement Overview

Summary
Financials are solid with a clear 2025 rebound: strong revenue growth (+28.3% YoY) and improved margins, supported by low leverage (debt-to-equity ~0.11–0.19) and consistently positive free cash flow. The main constraint is cyclicality and that profitability/cash conversion remain below the 2021–2022 peak efficiency.
Income Statement
68
Positive
Balance Sheet
80
Positive
Cash Flow
72
Positive
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue3.75B3.95B4.05B5.87B5.19B
Gross Profit1.29B1.16B1.06B2.12B2.34B
EBITDA1.10B693.50M597.02M1.51B1.72B
Net Income558.26M482.28M400.67M1.16B1.29B
Balance Sheet
Total Assets7.72B7.20B7.03B7.08B7.62B
Cash, Cash Equivalents and Short-Term Investments162.83M290.66M263.67M421.70M324.88M
Total Debt787.17M653.06M678.91M746.46M1.04B
Total Liabilities1.39B1.26B1.23B1.44B2.04B
Stockholders Equity6.33B5.94B5.80B5.63B5.57B
Cash Flow
Free Cash Flow478.88M282.02M142.21M955.86M762.12M
Operating Cash Flow991.32M1.06B756.45M1.57B1.43B
Investing Cash Flow-443.53M-826.47M-613.69M-610.62M-636.18M
Financing Cash Flow-611.88M-265.43M-298.37M-840.28M-919.87M

Lee & Man Chemical Co. Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price5.23
Price Trends
50DMA
5.76
Negative
100DMA
5.59
Negative
200DMA
5.11
Negative
Market Momentum
MACD
-0.24
Positive
RSI
34.06
Neutral
STOCH
6.48
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0746, the sentiment is Negative. The current price of 5.23 is below the 20-day moving average (MA) of 5.40, below the 50-day MA of 5.76, and above the 200-day MA of 5.11, indicating a bearish trend. The MACD of -0.24 indicates Positive momentum. The RSI at 34.06 is Neutral, neither overbought nor oversold. The STOCH value of 6.48 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0746.

Lee & Man Chemical Co. Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
HK$4.09B7.746.29%6.70%-3.73%6.09%
62
Neutral
HK$18.43B10.1810.22%0.98%-1.43%113.67%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
61
Neutral
HK$1.19B18.522.46%3.52%-5.29%-32.47%
59
Neutral
HK$1.24B7.693.65%2.20%-8.51%-68.34%
54
Neutral
HK$13.90B87.42-0.50%1.16%-15.17%-125.24%
52
Neutral
HK$6.02B8.0713.43%9.20%213.87%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:0746
Lee & Man Chemical Co. Ltd.
4.96
1.76
55.00%
HK:1907
China Risun Group Ltd.
3.12
0.67
27.14%
HK:0609
Tiande Chemical Holdings Limited
1.35
0.40
42.11%
HK:1702
Dongguang Chemical Ltd.
1.99
0.50
33.56%
HK:0189
Dongyue Group Limited
11.13
3.51
46.06%
HK:2198
China Sanjiang Fine Chemicals Co., Ltd.
5.13
3.63
242.00%

Lee & Man Chemical Co. Ltd. Corporate Events

Lee & Man Chemical Sets 2026 AGM to Approve Dividend, Board Mandate and Audit Matters
Mar 24, 2026
Lee Man Chemical Company Limited has called its annual general meeting for 29 April 2026 in Hong Kong, where shareholders will vote on adopting the audited financial statements for the year ended 31 December 2025 and the declaration of a final di...
Lee & Man Chemical Lifts Profit and Dividend Despite Revenue Dip in 2025
Mar 10, 2026
Lee Man Chemical reported a slight decline in revenue to HK$3.75 billion for 2025, but boosted gross profit margin by 5 percentage points to 34.5% as lower raw material and energy costs supported profitability. Net profit rose 15.8% to HK$558 mil...
Lee & Man Chemical Declares Final HKD 0.14 Dividend for 2025
Mar 10, 2026
Lee Man Chemical Company Limited has declared a final ordinary cash dividend of HKD 0.14 per share for the financial year ended 31 December 2025, subject to shareholder approval on 29 April 2026. The shares will trade ex-dividend on 4 May 2026, w...
Lee & Man Chemical Sets March Board Meeting to Approve 2025 Results and Consider Dividend
Feb 26, 2026
Lee Man Chemical Company Limited has scheduled a board meeting for 10 March 2026 to review and approve the annual results of the company and its subsidiaries for the financial year ended 31 December 2025, and to authorize their release to the mar...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 30, 2026